Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy

doi:10.3748/wjg.v23.i11.2060

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8885)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

542

WORD

328

HTML

4662

Figures (1-3)

137

Tables (1-3)

169

Sum=5838

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1122

Download

1925

Sum=3047

Mar 21, 2017 (publication date) through Apr 29, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Mar 21, 2017; 23(11): 2060-2067
Published online Mar 21, 2017. doi: 10.3748/wjg.v23.i11.2060

Full Size Figure Download Figure

Figure 1 Distribution of frequency scale for symptoms of gastroesophageal reflux disease scores in the present study. FSSG: Frequency scale for symptoms of gastroesophageal reflux disease.

Citation: Kawara F, Fujita T, Morita Y, Uda A, Masuda A, Saito M, Ooi M, Ishida T, Kondo Y, Yoshida S, Okuno T, Yano Y, Yoshida M, Kutsumi H, Hayakumo T, Yamashita K, Hirano T, Hirai M, Azuma T. Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy. World J Gastroenterol 2017; 23(11): 2060-2067
URL: https://www.wjgnet.com/1007-9327/full/v23/i11/2060.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i11.2060